Sunday, May 11, 2025
  • Business
  • Investing
  • World-news
  • Stock
No Result
View All Result
Finance Mastery News
Advertisement
  • Business
  • Investing
  • World-news
  • Stock
No Result
View All Result
Finance Mastery News
No Result
View All Result
Home Investing

Cardiol Therapeutics Announces Exercise and Closing of Over-Allotment Option

admin by admin
October 12, 2024
in Investing
0
Cardiol Therapeutics Announces Exercise and Closing of Over-Allotment Option
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) (‘Cardiol’ or the ‘Company’), a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease, is pleased to announce that, further to its successfully completed public offering of an aggregate of 8,437,500 Class A common shares of the Company (the ‘Common Shares’) at a price to the public of US$1.60 per Common Share (the ‘Offering Price’) for gross proceeds of US$13.5 million (the ‘Offering’), Canaccord Genuity has purchased an additional 1,265,625 Common Shares at the Offering Price pursuant to their exercise in full of the over-allotment option (the ‘Over-Allotment Option’), for additional gross proceeds to the Company of $2,025,000 before deducting the underwriting commissions.

After giving effect to the full exercise of the Over-Allotment Option, Cardiol sold 9,703,125 Common Shares under the Offering, for aggregate gross proceeds of US$15,525,000.

The Company intends to use the net proceeds from the Offering to support the clinical development of CardiolRx for the treatment of recurrent pericarditis and for general and administrative expenses, working capital and other expenses.

Canaccord Genuity acted as the sole bookrunner in connection with the Offering.

The Offering was made pursuant to a U.S. registration statement on Form F-10, declared effective by the U.S. Securities and Exchange Commissions (the ‘SEC’) on July 16, 2024 (the ‘Registration Statement’), and the Company’s existing Canadian short form base shelf prospectus (the ‘Base Prospectus’) dated July 12, 2024. A preliminary prospectus supplement relating to the Offering was filed with the securities commission in all of the provinces and territories of Canada, except Quebec, and with the SEC in the United States, and a final prospectus supplement relating to the Offering (the ‘Supplement’) was filed with the securities commissions in all of the provinces and territories of Canada, except Quebec, and with the SEC in the United States. The Supplement and accompanying Base Prospectus contain important detailed information about the Offering.

The Supplement and accompanying Base Prospectus can be found on SEDAR+ at www.sedarplus.ca and on EDGAR at www.sec.gov. Copies of the Supplement and accompanying Base Prospectus may also be obtained from Canaccord Genuity LLC, 1 Post Office Square, Suite 3000, Boston, Massachusetts 02109, Attn: Syndicate Department, or by email at prospectus@cgf.com.

This news release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any province, state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such province, state or jurisdiction.

About Cardiol Therapeutics

Cardiol Therapeutics Inc. is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease.

Cautionary statement regarding forward-looking information:

This news release contains ‘forward-looking information’ within the meaning of applicable securities laws. All statements, other than statements of historical fact, that address activities, events, or developments that Cardiol believes, expects, or anticipates will, may, could, or might occur in the future are ‘forward-looking information’. Forward looking information contained herein may include, but is not limited to statements regarding the anticipated use of proceeds from the Offering. Forward-looking information contained herein reflects the current expectations or beliefs of Cardiol based on information currently available to it and is based on certain assumptions and is also subject to a variety of known and unknown risks and uncertainties and other factors that could cause the actual events or results to differ materially from any future results, performance or achievements expressed or implied by the forward looking information, and are not (and should not be considered to be) guarantees of future performance. These risks and uncertainties and other factors include the risks and uncertainties referred to in the Company’s Annual Report on Form 20-F filed with the U.S. Securities and Exchange Commission and Canadian securities regulators on April 1, 2024, as well as the risks and uncertainties associated with product commercialization and clinical studies. These assumptions, risks, uncertainties, and other factors should be considered carefully, and investors should not place undue reliance on the forward-looking information, and such information may not be appropriate for other purposes. Any forward-looking information speaks only as of the date of this press release and, except as may be required by applicable securities laws, Cardiol disclaims any intent or obligation to update or revise such forward-looking information, whether as a result of new information, future events, or results, or otherwise. Investors are cautioned not to rely on these forward-looking statements and are encouraged to read the Supplement, the accompanying Base Prospectus and the documents incorporated by reference therein.

For further information, please contact:

Trevor Burns, Investor Relations +1-289-910-0855
trevor.burns@cardiolrx.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/226366

News Provided by Newsfile via QuoteMedia

This post appeared first on investingnews.com

Previous Post

West High YieldResources Ltd. Announces Extension of Current Private Placement

Next Post

The One Volume Indicator You Should Follow

admin

admin

Next Post
The One Volume Indicator You Should Follow

The One Volume Indicator You Should Follow

    Fill Out & Get More Relevant News


    Stay ahead of the market and unlock exclusive trading insights & timely news. We value your privacy - your information is secure, and you can unsubscribe anytime. Gain an edge with hand-picked trading opportunities, stay informed with market-moving updates, and learn from expert tips & strategies.

    • Trending
    • Comments
    • Latest
    Criminals are looting millions from ATMs in Europe. Here’s why Germany is a prime target

    Criminals are looting millions from ATMs in Europe. Here’s why Germany is a prime target

    October 28, 2024
    Israeli MP behind bill to expel key UN agency accuses US of interfering with process

    Israeli MP behind bill to expel key UN agency accuses US of interfering with process

    October 28, 2024
    British nurse Lucy Letby loses bid to appeal single attempted murder conviction

    British nurse Lucy Letby loses bid to appeal single attempted murder conviction

    October 25, 2024
    North Korean troops spotted in Russian border region with Ukraine, says Kyiv

    North Korean troops spotted in Russian border region with Ukraine, says Kyiv

    October 25, 2024
    Putin, Xi and friendly world leaders celebrate Russia’s Victory Day at Moscow Parade

    Putin, Xi and friendly world leaders celebrate Russia’s Victory Day at Moscow Parade

    0
    Private payroll growth slowed to 122,000 in July, less than expected, ADP says

    Private payroll growth slowed to 122,000 in July, less than expected, ADP says

    0
    The 10 worst states to retire in the U.S. No. 1 isn’t California or New York

    The 10 worst states to retire in the U.S. No. 1 isn’t California or New York

    0
    Boeing taps aerospace veteran Ortberg to replace Dave Calhoun as CEO

    Boeing taps aerospace veteran Ortberg to replace Dave Calhoun as CEO

    0
    Putin, Xi and friendly world leaders celebrate Russia’s Victory Day at Moscow Parade

    Putin, Xi and friendly world leaders celebrate Russia’s Victory Day at Moscow Parade

    May 10, 2025
    Ellen Miles is planting seeds of hope through guerrilla gardening

    Ellen Miles is planting seeds of hope through guerrilla gardening

    May 10, 2025
    Sycamore Gap: Two men convicted of felling one of UK’s most famous trees

    Sycamore Gap: Two men convicted of felling one of UK’s most famous trees

    May 10, 2025
    Ukraine says it has uncovered Hungarian spy network working in border region

    Ukraine says it has uncovered Hungarian spy network working in border region

    May 10, 2025

    Recent News

    Putin, Xi and friendly world leaders celebrate Russia’s Victory Day at Moscow Parade

    Putin, Xi and friendly world leaders celebrate Russia’s Victory Day at Moscow Parade

    May 10, 2025
    Ellen Miles is planting seeds of hope through guerrilla gardening

    Ellen Miles is planting seeds of hope through guerrilla gardening

    May 10, 2025
    Sycamore Gap: Two men convicted of felling one of UK’s most famous trees

    Sycamore Gap: Two men convicted of felling one of UK’s most famous trees

    May 10, 2025
    Ukraine says it has uncovered Hungarian spy network working in border region

    Ukraine says it has uncovered Hungarian spy network working in border region

    May 10, 2025

    Disclaimer: financemasterynews.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Browse by Category

    • Business
    • Investing
    • Stock
    • World-news

    Recent News

    Putin, Xi and friendly world leaders celebrate Russia’s Victory Day at Moscow Parade

    Putin, Xi and friendly world leaders celebrate Russia’s Victory Day at Moscow Parade

    May 10, 2025
    Ellen Miles is planting seeds of hope through guerrilla gardening

    Ellen Miles is planting seeds of hope through guerrilla gardening

    May 10, 2025
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 financemasterynews.com | All Rights Reserved

    No Result
    View All Result

    Copyright © 2025 financemasterynews.com | All Rights Reserved